Assignee
ACTYM THERAPEUTICS INC
US·9 granted patents·6 pending applications·13 citations·filing 2018–2025
Top patents by PatentIndex Score
15 records- 0189US11779612B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2019·Granted Oct 10, 2023·3 cites·60 claims
- 0289US11168326B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2018·Granted Nov 9, 2021·5 cites·38 claims
- 0388US11242528B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2019·Granted Feb 8, 2022·3 cites·35 claims
- 0484US12024709B2Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironmentACTYM THERAPEUTICS INC·Filed 2020·Granted Jul 2, 2024·2 cites·47 claims
- 0580US12226439B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2022·Granted Feb 18, 2025·0 cites·41 claims
- 0680US2025345369A1Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0779US12201653B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2022·Granted Jan 21, 2025·0 cites·29 claims
- 0871US12553047B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2021·Granted Feb 17, 2026·0 cites·17 claims
- 0971US12357661B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2020·Granted Jul 15, 2025·0 cites·37 claims
- 1071US12012600B2Engineered immunostimulatory bacterial strains and uses thereofACTYM THERAPEUTICS INC·Filed 2021·Granted Jun 18, 2024·0 cites·32 claims
- 1161US2024293478A1Immunostimulatory bacteria for converting macrophages into a phenotype amenable to treatment, and companion diagnostic for identifying subjects for treatmentACTYM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1258US2022154136A1Immunostimulatory bacteria delivery platforms and their use for delivery of therapeutic productsACTYM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1355US2022380720A1Immunostimulatory bacteria delivery platforms and their use for delivery of therapeutic productsACTYM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1453US2022119824A1Immunostimulatory bacteria-based vaccines, therapeutics, and rna delivery platformsACTYM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1553US2022135980A1Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironmentACTYM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ACTYM THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →